Featured Posts
National Review
Prescription Drugs Save Lives at a (Mostly) Reasonable Cost
Prescription drugs are an extraordinary lifesaving and life-enhancing technology, so integrated into our daily lives that, nowadays, we perhaps take them for granted. Headlines and…
News Release
FDA deserves credit for approval pancreatic cancer drug
The FDA on August 26 approved a new breakthrough drug to treat pancreatic cancer. CEI Senior Fellow and Economist Jeremy Nighohossian praised…
Blog
Fauci’s lasting legacy will be the damage he did to science and government
Anthony Fauci isn’t faring well in the court of public opinion. His recently divulged “diary” and subsequent July 29 appearance before the Senate Homeland…
Search Posts
Op-Eds
Good Drugs, Bad Rap
These are turbulent times for the pharmaceutical industry and for its regulator, the FDA. Lately, both have focused increasingly on issues of safety.
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. REGULATORY COSTS President Bush speaks about controlling the costs imposed on business by regulatory expenses. CEI…
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. GLOBAL WARMING The US maintains its opposition to forced emissions cuts at the UN climate…
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. HEALTH & SAFETY The SEC changes rules that would have hindered efforts to fight avian flu.
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. GLOBAL WARMING Attendees to the U.N. climate conference in Montreal are unlikely to set…
News Release
SEC Changes Policy to Combat Potential Bird Flu Epidemic
Washington, D.C., December 6, 2005—In a move that could save thousands of lives, the U.S. Securities and Exchange Commission has cleared the red tape of…